Hendershot Investments’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-53,319
Closed -$3.82M 69
2016
Q4
$3.82M Sell
53,319
-26,224
-33% -$1.95M 1.83% 24
2016
Q3
$6.29M Sell
79,543
-1,917
-2% -$156K 3.12% 8
2016
Q2
$6.79M Sell
81,460
-60
-0.1% -$5.33K 3.49% 6
2016
Q1
$7.49M Buy
81,520
+3,525
+5% +$318K 3.77% 5
2015
Q4
$7.89M Buy
77,995
+1,913
+3% +$199K 4.22% 4
2015
Q3
$7.47M Sell
76,082
-165
-0.2% -$18.3K 4.15% 3
2015
Q2
$8.93M Buy
76,247
+1,579
+2% +$173K 4.67% 3
2015
Q1
$7.33M Buy
74,668
+30,308
+68% +$3.08M 3.86% 4
2014
Q4
$4.18M Buy
44,360
+2,225
+5% +$230K 2.19% 20
2014
Q3
$4.49M Buy
42,135
+11,470
+37% +$1.12M 2.53% 12
2014
Q2
$2.54M Buy
30,665
+19,065
+164% +$1.48M 1.5% 29
2014
Q1
$822K Sell
11,600
-30
-0.3% -$2.35K 0.51% 46
2013
Q4
$873K Hold
11,630
0.57% 45
2013
Q3
$731K Hold
11,630
0.51% 45
2013
Q2
$596K Buy
+11,630
New +$606K 0.45% 43

Other funds holding GILD

Hendershot Investments's GILD Position: Q1 2017 in Review

Hendershot Investments sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 53,319 shares — an estimated $3.82M sold.

Hendershot Investments first reported a position in GILD in Q2 2013 and held it in 15 quarters. The position peaked at $8.93M in Q2 2015. 1,525 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • Hendershot Investments reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
  • Hendershot Investments sold 53,319 Gilead Sciences shares in Q1 2017, an estimated $3.82M.
  • Hendershot Investments first reported a position in Gilead Sciences in Q2 2013 and held it in 15 quarters.
  • Hendershot Investments's Gilead Sciences position peaked at $8.93M in Q2 2015.
  • 1,525 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on Hendershot Investments's 13F filing for Q1 2017, filed 12 May 2017.